Vaccination adherence to influenza,pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients |
| |
| Affiliation: | 1. Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain;2. Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain;3. Córdoba Medicine School, Córdoba University, Córdoba, Spain;4. Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain;1. Dasman Diabetes Institute, Kuwait City, Kuwait;2. Faculty of Medicine and Faculty of Public Health, Kuwait University, Kuwait;3. School of Health and Life Sciences, Teesside University, United Kingdom;4. Ministry of Health, Kuwait;5. Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland;1. Department of Gerontology, The People’s Hospital of LeShan, 614000 LeShan, China;2. Department of Endocrinology, The Affiliated Hospital of XiNan Medical University, 641400 Luzhou, China;1. Vascular Surgery Unit, Department of General Surgery, Faculty of Medicine, National University of Malaysia Medical Centre, 50603 Kuala Lumpur, Malaysia;2. Department of Surgery, Hospital Sultanah Aminah, Johor Bahru, Malaysia;3. Department of Computer and Communication Systems Engineering, Faculty of Engineering, Universiti Putra Malaysia;1. Servicio de Oncología Médica, Hospital San Pedro de Alcántara, Cáceres, España;2. Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, España;1. Department of Nursing, Suzhou Vocational Health College, Suzhou, Jiangsu, China;2. Department of Medical Science, Suzhou Vocational Health College, Suzhou, Jiangsu, China |
| |
| Abstract: | AimTo document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients.Materials and methodsObservational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status.ResultsThree hundred patients were analyzed (male 53%). Mean age was 40.0 ± 14.4 years and T1DM duration was 19.7 ± 11.8 years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up.ConclusionsThe uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254. |
| |
| Keywords: | Vaccination Influenza Pneumococcal HBV Type 1 diabetes |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
